2026 Q1 -tulosraportti
Vain PDF
54 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·10 t sittenToday is the last day of Q2. Lately, there have been almost no trades with this stock. This means that many have bought up and stored the shares in their holdings. I can inform that it seems Weeco Pharma's campaign, where customers can buy 1 kg. flower medicine cheaply, has worked on some wholesalers, because this morning I can see on the stock list. that there are some who have more products with Weeco than there have been previously. Then we will see if it also entails that they will be approved to also have Astrum10-10 in their assortment. Fortunately, Germany has thrown the abacus in the trash and gone digital, so therefore the settlement with Stenocare will also proceed faster than it has done previously, and if there is an upward adjustment, we must expect it to come at the very latest in 3 weeks, but Stenocare's management must send out a notification as soon as they can see that sales in Germany are surprisingly positive. The only thing we can do now is to be patient, and wait tick tock tick tockAnother thing, regardless of whether they get a decent intro down there, Germany accounts for almost nothing in Stenocare's financial report, whereas Denmark, on the other hand, accounts for everything. This means that it is the situation and sales in Denmark that entirely determine whether Stenocare's next financial report will be good. If customers here have started buying competitor's products, or if a price war has broken out in Denmark, then very little adversity in dk will be needed to outweigh even a decent intro in Germany. And yet, even though dk accounts for everything, and even though Germany accounts for close to nothing, 3 d does not at all follow how things are going in Stenocare's overwhelmingly largest market. Blueocean could probably tell the forum how things are going with the all-decisive price discipline in dk, but unfortunately, I sense that he has completely given up writing here, because 3D fills the Forum with all his irrelevant AI nonsense, and that is a huge loss for the chat, as Blueocean's info is relevant, unlike 3D's guesses and dreams.- ·3 päivää sittenI just stumbled upon this documentary film about how easy it is to get flower cannabis medicine on prescription, in Germany. This is right up Minister of Health Nina Warkens' alley, because she has been a fierce opponent of flowers and vaporizers receiving subsidies when the bill was to be approved. Subsequently, she became Minister of Health, and now that she is minister, her views have only been strengthened by the fact that the expenses for flowers and vaporizers have increased by 400% in 2 years. (see previous link) Even though the proposal has only gone through its 1st reading, there is probably no doubt that it will also pass the 2nd and 3rd readings. One's death is another's bread. I wonder if some of these users will get prescriptions for Weeco astrum10-10 instead. https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae
·25.6.So patience ran out sold and Circio Holding bought.... have a nice day and good luck to those of you who are still holding out- ·24.6.I have written several times that the subsidy for flowers and vapor will end as of January 1, 2027. Since I could not see any signs that the industry itself, which deals with flowers and vapor, did not seem to react and start getting oils and extracts into their assortment, I began to wonder if I am the only one who has seen it and understood that the subsidy is stopping? No, fortunately, that's not the case, Weeco pharma has also understood it. This summer they are running an aggressive campaign, simultaneously with a campaign for Weeco astrum, so that new customers (B2B) can buy 1 kg. flower medicine cheaply while supplies last. This campaign is to snatch as many new customers as possible from businesses that only deal with flowers and vapor, so that before the subsidy is removed, they get Weeco astrum into their assortment. Unfortunately, it's not only Weeco Pharma that is being aggressive, the other wholesalers are too. https://weeco.com/https://weeco.com/astrum/Koalastar I respect his decision, but I can't help but wonder, because the new company he is investing in has just had a share issue of 300 mill. NOK and these shares have not yet landed on the stock exchange. and for that reason, it will be impossible to keep the price up. I have found out many things about Weeco astrum10-10 in Germany. I started on May 13. If you take the trouble, you can see with your own eyes that Stenocare's business in Germany is doing quite well. He also had the same information, so it's even stranger that he didn't have the patience to wait approx. 14 days to find out if there will be an upward adjustment, and how big it will be. https://www.circio.com/en/circio-completes-transformational-fundraising-of-nok-300-million-to-strengthen-its-position-as-the-global-leader-in-circular-rna-based-gene-expression-systems/
- ·23.6. · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
54 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·10 t sittenToday is the last day of Q2. Lately, there have been almost no trades with this stock. This means that many have bought up and stored the shares in their holdings. I can inform that it seems Weeco Pharma's campaign, where customers can buy 1 kg. flower medicine cheaply, has worked on some wholesalers, because this morning I can see on the stock list. that there are some who have more products with Weeco than there have been previously. Then we will see if it also entails that they will be approved to also have Astrum10-10 in their assortment. Fortunately, Germany has thrown the abacus in the trash and gone digital, so therefore the settlement with Stenocare will also proceed faster than it has done previously, and if there is an upward adjustment, we must expect it to come at the very latest in 3 weeks, but Stenocare's management must send out a notification as soon as they can see that sales in Germany are surprisingly positive. The only thing we can do now is to be patient, and wait tick tock tick tockAnother thing, regardless of whether they get a decent intro down there, Germany accounts for almost nothing in Stenocare's financial report, whereas Denmark, on the other hand, accounts for everything. This means that it is the situation and sales in Denmark that entirely determine whether Stenocare's next financial report will be good. If customers here have started buying competitor's products, or if a price war has broken out in Denmark, then very little adversity in dk will be needed to outweigh even a decent intro in Germany. And yet, even though dk accounts for everything, and even though Germany accounts for close to nothing, 3 d does not at all follow how things are going in Stenocare's overwhelmingly largest market. Blueocean could probably tell the forum how things are going with the all-decisive price discipline in dk, but unfortunately, I sense that he has completely given up writing here, because 3D fills the Forum with all his irrelevant AI nonsense, and that is a huge loss for the chat, as Blueocean's info is relevant, unlike 3D's guesses and dreams.
- ·3 päivää sittenI just stumbled upon this documentary film about how easy it is to get flower cannabis medicine on prescription, in Germany. This is right up Minister of Health Nina Warkens' alley, because she has been a fierce opponent of flowers and vaporizers receiving subsidies when the bill was to be approved. Subsequently, she became Minister of Health, and now that she is minister, her views have only been strengthened by the fact that the expenses for flowers and vaporizers have increased by 400% in 2 years. (see previous link) Even though the proposal has only gone through its 1st reading, there is probably no doubt that it will also pass the 2nd and 3rd readings. One's death is another's bread. I wonder if some of these users will get prescriptions for Weeco astrum10-10 instead. https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae
- ·25.6.So patience ran out sold and Circio Holding bought.... have a nice day and good luck to those of you who are still holding out
- ·24.6.I have written several times that the subsidy for flowers and vapor will end as of January 1, 2027. Since I could not see any signs that the industry itself, which deals with flowers and vapor, did not seem to react and start getting oils and extracts into their assortment, I began to wonder if I am the only one who has seen it and understood that the subsidy is stopping? No, fortunately, that's not the case, Weeco pharma has also understood it. This summer they are running an aggressive campaign, simultaneously with a campaign for Weeco astrum, so that new customers (B2B) can buy 1 kg. flower medicine cheaply while supplies last. This campaign is to snatch as many new customers as possible from businesses that only deal with flowers and vapor, so that before the subsidy is removed, they get Weeco astrum into their assortment. Unfortunately, it's not only Weeco Pharma that is being aggressive, the other wholesalers are too. https://weeco.com/https://weeco.com/astrum/Koalastar I respect his decision, but I can't help but wonder, because the new company he is investing in has just had a share issue of 300 mill. NOK and these shares have not yet landed on the stock exchange. and for that reason, it will be impossible to keep the price up. I have found out many things about Weeco astrum10-10 in Germany. I started on May 13. If you take the trouble, you can see with your own eyes that Stenocare's business in Germany is doing quite well. He also had the same information, so it's even stranger that he didn't have the patience to wait approx. 14 days to find out if there will be an upward adjustment, and how big it will be. https://www.circio.com/en/circio-completes-transformational-fundraising-of-nok-300-million-to-strengthen-its-position-as-the-global-leader-in-circular-rna-based-gene-expression-systems/
- ·23.6. · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
54 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·10 t sittenToday is the last day of Q2. Lately, there have been almost no trades with this stock. This means that many have bought up and stored the shares in their holdings. I can inform that it seems Weeco Pharma's campaign, where customers can buy 1 kg. flower medicine cheaply, has worked on some wholesalers, because this morning I can see on the stock list. that there are some who have more products with Weeco than there have been previously. Then we will see if it also entails that they will be approved to also have Astrum10-10 in their assortment. Fortunately, Germany has thrown the abacus in the trash and gone digital, so therefore the settlement with Stenocare will also proceed faster than it has done previously, and if there is an upward adjustment, we must expect it to come at the very latest in 3 weeks, but Stenocare's management must send out a notification as soon as they can see that sales in Germany are surprisingly positive. The only thing we can do now is to be patient, and wait tick tock tick tockAnother thing, regardless of whether they get a decent intro down there, Germany accounts for almost nothing in Stenocare's financial report, whereas Denmark, on the other hand, accounts for everything. This means that it is the situation and sales in Denmark that entirely determine whether Stenocare's next financial report will be good. If customers here have started buying competitor's products, or if a price war has broken out in Denmark, then very little adversity in dk will be needed to outweigh even a decent intro in Germany. And yet, even though dk accounts for everything, and even though Germany accounts for close to nothing, 3 d does not at all follow how things are going in Stenocare's overwhelmingly largest market. Blueocean could probably tell the forum how things are going with the all-decisive price discipline in dk, but unfortunately, I sense that he has completely given up writing here, because 3D fills the Forum with all his irrelevant AI nonsense, and that is a huge loss for the chat, as Blueocean's info is relevant, unlike 3D's guesses and dreams.
- ·3 päivää sittenI just stumbled upon this documentary film about how easy it is to get flower cannabis medicine on prescription, in Germany. This is right up Minister of Health Nina Warkens' alley, because she has been a fierce opponent of flowers and vaporizers receiving subsidies when the bill was to be approved. Subsequently, she became Minister of Health, and now that she is minister, her views have only been strengthened by the fact that the expenses for flowers and vaporizers have increased by 400% in 2 years. (see previous link) Even though the proposal has only gone through its 1st reading, there is probably no doubt that it will also pass the 2nd and 3rd readings. One's death is another's bread. I wonder if some of these users will get prescriptions for Weeco astrum10-10 instead. https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae
- ·25.6.So patience ran out sold and Circio Holding bought.... have a nice day and good luck to those of you who are still holding out
- ·24.6.I have written several times that the subsidy for flowers and vapor will end as of January 1, 2027. Since I could not see any signs that the industry itself, which deals with flowers and vapor, did not seem to react and start getting oils and extracts into their assortment, I began to wonder if I am the only one who has seen it and understood that the subsidy is stopping? No, fortunately, that's not the case, Weeco pharma has also understood it. This summer they are running an aggressive campaign, simultaneously with a campaign for Weeco astrum, so that new customers (B2B) can buy 1 kg. flower medicine cheaply while supplies last. This campaign is to snatch as many new customers as possible from businesses that only deal with flowers and vapor, so that before the subsidy is removed, they get Weeco astrum into their assortment. Unfortunately, it's not only Weeco Pharma that is being aggressive, the other wholesalers are too. https://weeco.com/https://weeco.com/astrum/Koalastar I respect his decision, but I can't help but wonder, because the new company he is investing in has just had a share issue of 300 mill. NOK and these shares have not yet landed on the stock exchange. and for that reason, it will be impossible to keep the price up. I have found out many things about Weeco astrum10-10 in Germany. I started on May 13. If you take the trouble, you can see with your own eyes that Stenocare's business in Germany is doing quite well. He also had the same information, so it's even stranger that he didn't have the patience to wait approx. 14 days to find out if there will be an upward adjustment, and how big it will be. https://www.circio.com/en/circio-completes-transformational-fundraising-of-nok-300-million-to-strengthen-its-position-as-the-global-leader-in-circular-rna-based-gene-expression-systems/
- ·23.6. · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt